Tag: Clinical trials

Search News
Categories
Archives
Immunotherapy for advanced bladder cancer

29th May 2020

An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.

Read more

Immune therapy reduces risk of recurrence in aggressive breast cancer

27th February 2020

An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Barts Cancer Institute, Queen Mary University of London.

Read more

KEYNOTE-522: Immune therapy for breast cancer

30th September 2019

Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.

Read more

Urine test for pancreatic cancer starts clinical study

25th September 2019

A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients. If successful, this non-invasive urine test would be the first in the world to help clinicians detect the highly lethal cancer at an early stage – enabling many more people to have surgery to remove their tumour, which is currently the only potentially curative treatment.

Read more

International Clinical Trials Day

20th May 2019

Every 20th May, we celebrate International Clinical Trials Day. Clinical methods have evolved drastically over the years, and decades of honing this process has given rise to the present-day standard of clinical trials.

Read more

Treatment for advanced kidney cancer

13th February 2019

A combination therapy has shown powerful anticancer responses in patients with a type of advanced kidney cancer in a new international phase III clinical trial (KEYNOTE-426). Treatment with the combination therapy resulted in significant increases in overall survival when compared with the current standard of care, and the findings will help to provide a vital new treatment option for patients with this disease.

Read more

Search News
Categories
Archives
Upcoming Events
  1. MSc Cancer Programmes Live Q&A Event

    July 27 @ 1:00 pm - 4:30 pm
  2. The London Pancreas Workshop 2020

    September 11 @ 9:30 am - 4:30 pm
© 2013 ~ 2020 Cancer Research UK Barts Centre